Correlation Between Design Therapeutics and ZyVersa Therapeutics
Can any of the company-specific risk be diversified away by investing in both Design Therapeutics and ZyVersa Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Design Therapeutics and ZyVersa Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Design Therapeutics and ZyVersa Therapeutics, you can compare the effects of market volatilities on Design Therapeutics and ZyVersa Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Design Therapeutics with a short position of ZyVersa Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Design Therapeutics and ZyVersa Therapeutics.
Diversification Opportunities for Design Therapeutics and ZyVersa Therapeutics
-0.68 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Design and ZyVersa is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Design Therapeutics and ZyVersa Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ZyVersa Therapeutics and Design Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Design Therapeutics are associated (or correlated) with ZyVersa Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ZyVersa Therapeutics has no effect on the direction of Design Therapeutics i.e., Design Therapeutics and ZyVersa Therapeutics go up and down completely randomly.
Pair Corralation between Design Therapeutics and ZyVersa Therapeutics
Given the investment horizon of 90 days Design Therapeutics is expected to generate 0.49 times more return on investment than ZyVersa Therapeutics. However, Design Therapeutics is 2.04 times less risky than ZyVersa Therapeutics. It trades about 0.02 of its potential returns per unit of risk. ZyVersa Therapeutics is currently generating about -0.15 per unit of risk. If you would invest 566.00 in Design Therapeutics on August 24, 2024 and sell it today you would lose (9.00) from holding Design Therapeutics or give up 1.59% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Design Therapeutics vs. ZyVersa Therapeutics
Performance |
| Timeline |
| Design Therapeutics |
| ZyVersa Therapeutics |
Design Therapeutics and ZyVersa Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Design Therapeutics and ZyVersa Therapeutics
The main advantage of trading using opposite Design Therapeutics and ZyVersa Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Design Therapeutics position performs unexpectedly, ZyVersa Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ZyVersa Therapeutics will offset losses from the drop in ZyVersa Therapeutics' long position.| Design Therapeutics vs. ZyVersa Therapeutics | Design Therapeutics vs. Sonnet Biotherapeutics Holdings | Design Therapeutics vs. Zura Bio Limited | Design Therapeutics vs. Phio Pharmaceuticals Corp |
| ZyVersa Therapeutics vs. Cns Pharmaceuticals | ZyVersa Therapeutics vs. Immix Biopharma | ZyVersa Therapeutics vs. Hepion Pharmaceuticals | ZyVersa Therapeutics vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk |